RT206 Couples Partial PPARα/γ Agonism with Ligand-Dependent Allosteric Potentiation of FXR Signaling in Liver Cells
Biomolecules · 2026
DOI: 10.3390/biom16091316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Manuela Leo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sciences and Technologies, University of Sannio, 82100 Benevento, Italy. Hauptthemen laut MEDLINE: PPAR alpha, Receptors, Cytoplasmic and Nuclear, PPAR gamma, Liver. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Universities and Research, Italian Ministry of Universities and Research, University of Naples “Federico II”.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic disorder characterized by dysregulated lipid handling and bile acid signaling, processes controlled by PPARs and FXR. We report that RT206, a 2-aryloxy-3-phenyl-propanoic acid derivative, combines partial PPARα/γ agonism with positive allosteric modulation of FXR. Transactivation assays and endogenous gene-expression profiling confirmed activation of PPARα/γ-responsive genes. RT206 showed no intrinsic FXR agonism, yet it robustly potentiated FXR-dependent gene transcription in HepG2 cells in the presence of structurally distinct orthosteric agonists. Grating-coupled interferometry revealed weak interaction with apo-FXR that was enhanced by orthosteric ligands, consistent with cooperative ternary complex formation. Docking and molecular dynamics supported a model in which RT206 engages the non-orthosteric FXR S2 site, while orthosteric agonists occupy the S1 primary pocket. Comparison with guggulsterone revealed distinct predicted S2 interaction patterns associated with divergent transcriptional outcomes in vitro. In fatty acid-loaded HepG2 cells, RT206 combined with FXR agonists modulated FXR- and PPAR-regulated metabolic genes and modestly reduced neutral-lipid accumulation. These findings identify RT206 as a proof-of-principle scaffold that integrates partial PPARα/γ agonism with ligand-dependent potentiation of FXR activity and support its further evaluation in more advanced liver models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Sciences and Technologies, University of Sannio, 82100 Benevento, Italy.
- Drug Discovery Laboratory, Department of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.
- Department of Pharmacy-Drug Science, University of Bari "Aldo Moro", 70126 Bari, Italy.
- Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy.
ORCID-Profile: Manuela Leo, Carmen Cerchia, Antonio Laghezza, Francesca Rinaldi, Enrica Calleri, Fulvio Loiodice, Antonio Lavecchia
Förderung
- Ministry of Universities and Research
- Italian Ministry of Universities and Research
- University of Naples “Federico II”
Zitieren
APA
Leo, M., Cerchia, C., Laghezza, A., Rinaldi, F., Calleri, E., Colantuoni, V., Loiodice, F., Sabatino, L., & Lavecchia, A. (2026). RT206 Couples Partial PPARα/γ Agonism with Ligand-Dependent Allosteric Potentiation of FXR Signaling in Liver Cells. Biomolecules. https://doi.org/10.3390/biom16091316
Vancouver
Leo M, Cerchia C, Laghezza A, Rinaldi F, Calleri E, Colantuoni V, et al. RT206 Couples Partial PPARα/γ Agonism with Ligand-Dependent Allosteric Potentiation of FXR Signaling in Liver Cells. Biomolecules. 2026. doi:10.3390/biom16091316
BibTeX
@article{Leo2026,
author = {Leo, Manuela and Cerchia, Carmen and Laghezza, Antonio and Rinaldi, Francesca and Calleri, Enrica and Colantuoni, Vittorio and Loiodice, Fulvio and Sabatino, Lina and Lavecchia, Antonio},
title = {RT206 Couples Partial PPARα/γ Agonism with Ligand-Dependent Allosteric Potentiation of FXR Signaling in Liver Cells},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16091316}
}
EUVIMED